Efficacy and safety of retaspimycin hydrochloride (IPI-504) in combination with trastuzumab in patients (pts) with pretreated, locally advanced or metastatic HER2-positive breast cancer.
S. Modi
Research Funding - Infinity
C. Saura
No relevant relationships to disclose
C. A. Henderson
No relevant relationships to disclose
N. U. Lin
Research Funding - Boehringer Ingelheim; Genentech; GlaxoSmithKline
R. L. Mahtani
Honoraria - Genentech; Ortho Biotech
J. Goddard
Employment or Leadership Position - Infinity
Stock Ownership - Infinity
E. Rodenas
Employment or Leadership Position - Infinity
Stock Ownership - Infinity
J. O'Shaughnessy
No relevant relationships to disclose
J. Baselga
No relevant relationships to disclose